A Study to Evaluate the Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Trial Profile

A Study to Evaluate the Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2017

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Varicella zoster virus vaccine live (Primary)
  • Indications Chickenpox; Japanese encephalitis
  • Focus Therapeutic Use
  • Sponsors Changchun Keygen Biological Products
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top